Li et al. demonstrated that folic acid-functionalized ginger-derived nanovesicles (GDENs) effectively delivered survivin siRNA to cancer cells, achieving significant gene knockdown in vitro and inhibiting tumor growth in vivo, highlighting the therapeutic potential and cost-effectiveness of PDNVs in cancer treatment 71. The gene discussed is BIRC5; the disease is cancer.